跳至主要内容
临床试验/CTRI/2020/10/028755
CTRI/2020/10/028755尚未招募2 期

A Randomized Clinical Trial to Evaluate the Efficacy of Ayurvedic Compound in Shushkakshipaka w.s.r. to Computer and Visual Display Terminal Vision Syndrome (CVDTS)

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年2月11日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Evaluate the efficacy of Ayurvedic compound in computer and visual display terminal vision syndrome (CVDTS) W.S.R. to Shushkakshipaka

研究概览

简要总结

Purpose- To Evaluate the Efficacy of Ayurvedic Compound in Shushkakshipaka w.s.r. to Computer andVisual Display Terminal Vision Syndrome (CVDTS)

GROUP A: Tarpana with Chakshushya**Ghrita and oraladministration of Shadanga Guggulu Vati

GROUP B: oral administration of Shadanga Guggulu Vati

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients using computer at least 3 hours per day presenting with clinical features of
  • Netrayasa (Eye strain)
  • Avila Darshana (Blurred vision)
  • Shiro abhitapa (Headache)
  • Netra raga (conjunctival congestion)
  • NetraDaha (Burning sensation)
  • Vishushkatva (Dryness)
  • Slow refocusing
  • Excessive fatigue (Neck/Shoulder/Back pain).

排除标准

  • 1.Patient not willing for registration.
  • 2.Patients suffering from symptoms of dry eye due to causes other than excess exposure to visual display terminals.
  • 3.Patients suffering from systemic illness or taking medications which are known to affect tear quantity and quality.
  • 4.Complicated case with acute/chronic infective infections of lid, conjunctiva, cornea and sclera.

结局指标

主要结局

Evaluate the efficacy of Ayurvedic compound in computer and visual display terminal vision syndrome (CVDTS) W.S.R. to Shushkakshipaka

时间窗: 45 Days

次要结局

  • Any adverse event reported voluntarily, observed or enquire(45 Days)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验